Drug Trial Radar · NCT07061288
A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT
Last checked: Nov 20, 2026Latest source record: Sep 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
131
Planned (sponsor's estimate)
Start
Sep 3, 2025
Primary completion
Jun 21, 2027
Study completion Oct 15, 2027
Sponsor
- Lead sponsor
- Bristol-Myers SquibbBristol Myers Squibb (BMY)
- Sponsor type
- Industry
- First posted
- Jul 11, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A study to evaluate the safety, tolerability, and PK of an injectable form of KarXT in participants with schizophrenia
Conditions
- Schizophrenia
Interventions
KarXTDrug
Specified dose on specified days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of participants with adverse events (AEs)Time frame: Up to 3 weeks
- Number of participants with adverse events of special interest (AESIs)Time frame: Up to 3 weeks
- Number of participants with serious adverse events (SAEs)Time frame: Up to 3 weeks
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
Collaborative Neuroscience Research, LLC
Los Alamitos, California · Recruiting
Research Centers of America ( Hollywood )
Hollywood, Florida · Recruiting
Innovative Clinical Research, Inc.
Miami Lakes, Florida · Recruiting
Atlanta Center for Medical Research
Atlanta, Georgia · Recruiting
CenExel iResearch, LLC
Decatur, Georgia · Recruiting
Uptown Research Institute
Chicago, Illinois · Recruiting
Hassman Research Institute Marlton Site
Marlton, New Jersey · Recruiting
Community Clinical Research
Austin, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.